Follow The Filings

CNTX Context Therapeutics Inc.

Health Care, filed as CONTEXT THERAPEUTICS INC (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

  • 1 Owner
  • Max 0.4%
  • $2.8M

Who owns this now

Largest portfolio weights among holders, up to 0.4% (David Witzke, Avidity Partners Management). Not free-float ownership.

  1. David Witzke 0.44%

Who owns CNTX

Sorted by value, long equity only, as of 2026 Q2.

History
David Witzke, Avidity Partners Management 0.44% Hold 4,998,267 $2.8M History

1 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
10-Q Filing Doc
8-K 7.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 3.01 Filing Doc
SCHEDULE 13G — Filing Doc
8-K 5.03,5.07,9.01 Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
8-K 1.01,7.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
10-Q Filing Doc
8-K 8.01 Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
10-K Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
8-K 5.03,8.01,9.01 Filing Doc
8-K 8.01 Filing Doc
SCHEDULE 13G/A — Filing Doc

Insider forms

Forms 3, 4 and 5 from EDGAR, 2 rows shown

Filed Form Detail Links
4 Period Jun 24, 2026 (6 forms) Filing Doc
4 Period Feb 19, 2026 (4 forms) Filing Doc

Source: SEC EDGAR submissions, updated 15 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Net income -$23.96M -$26.73M -$36.12M

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $16.05M $97.9M $68.35M
Total non-current assets * $15,524 $230,775 $140,066
Total assets $16.06M $98.13M $68.49M
Total current liabilities $4.19M $2.75M $8.02M
Total non-current liabilities * $0.00 $112,064 $0.00
Total equity $11.87M $95.27M $60.47M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$21.05M -$14.56M -$26.39M
Cash from investing $0M -$14.76M -$2.03M
Cash from financing $0M $109.29M -$0.015M
Net change in cash -$21.05M $79.98M -$28.43M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf